Skip to main navigation
Go to  NovaBridge Biosciences logo
  • Home
  • About
    • Who We Are
    • Leadership Team
    • Contact
  • Innovation
    • Oncology
    • Ophthalmology (Visara)
    • Publications & Presentations
  • Pipeline
    • Pipeline
    • Clinical Trials
    • Expanded Access Policy
    • Externally Sponsored Research
  • News
  • Investors
    • Overview
    • Corporate
      • Corporate Profile
      • Corporate Governance
    • News & Events
      • News Releases
      • Event Calendar
      • Presentations & Webcasts
    • Stock
      • Stock Quote & Chart
      • Historical Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
      • Annual Reports
    • ESG
    • IR Resources
      • Investor FAQs
      • Email Alerts
      • Contact
  • Careers
  • Search Investors
Go to  NovaBridge Biosciences homepage
  • Home
  • About
    • Who We Are
    • Leadership Team
    • Contact
  • Innovation
    • Oncology
    • Ophthalmology (Visara)
    • Publications & Presentations
  • Pipeline
    • Pipeline
    • Clinical Trials
    • Expanded Access Policy
    • Externally Sponsored Research
  • News
  • Investors
    • Overview
    • Corporate
      • Corporate Profile
      • Corporate Governance
    • News & Events
      • News Releases
      • Event Calendar
      • Presentations & Webcasts
    • Stock
      • Stock Quote & Chart
      • Historical Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
      • Annual Reports
    • ESG
    • IR Resources
      • Investor FAQs
      • Email Alerts
      • Contact
  • Careers

Publications & Presentations

  • Givastomig
  • VIS-101
  • Ragistomig (ABL503)
  • Uliledlimab

Givastomig

More information is coming soon.

VIS-101

More information is coming soon.

Ragistomig (ABL503)

More information is coming soon.

Uliledlimab

More information is coming soon.

Events

Learn More

News Releases

Learn More

Presentations and Corporate Materials

Learn More

SEC Filings

Learn More

Stock Information

Learn More

Investor Inquiries

Learn More

Sitemap

  • Home
  • About
  • Innovation
  • Pipeline
  • News
  • Investors
  • Careers
  • Language Switcher

Follow Us

  • LinkedIn

Copyright © 2026 NovaBridge Biosciences. All Rights Reserved.

  • Terms of Use
  • Privacy Policy